Molecular mechanisms of membrane targeting antibiotics

Biochimica et Biophysica Acta - Biomembranes

Volumn 1858, Issue 5, 2016, Pages 980-987

  Epand, Richard M ^a   Walker, Chelsea ^a   Epand, Raquel F ^a   Magarvey, Nathan A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Cardiolipin; Lipid A; Lipopolysaccharide; Phosphatidylethanolamine

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARDIOLIPIN; CEPHALOSPORIN; CYCLOVIOLACIN O2; DAPTOMYCIN; FOSFOMYCIN; KALATA B1; KALATA B2; LANCOVUTIDE; LANTHIOPEPTIN; LYSOCIN E; MENAQUINONE; NISIN; PENICILLIN DERIVATIVE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID; POLYPEPTIDE ANTIBIOTIC AGENT; RO 48 071; TELOMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; LIPID A; LIPOPOLYSACCHARIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; BINDING SITE; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST CELL; LIPID COMPOSITION; LIPID METABOLISM; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; ANTAGONISTS AND INHIBITORS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CARDIOLIPINS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; LIPID A; LIPOPOLYSACCHARIDES; MOLECULAR TARGETED THERAPY; PHOSPHATIDYLETHANOLAMINES; SPECIES SPECIFICITY;

EID: 84962261758     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2015.10.018     Document Type: Article

References (85)

1. S. Reardon US vows to combat antibiotic resistance Nature 513 2014 471
2. V. Teixeira, M.J. Feio, and M. Bastos Role of lipids in the interaction of antimicrobial peptides with membranes Prog. Lipid Res. 51 2012 149 177
3. D. Alves, and P.M. Olivia Mini-review: antimicrobial peptides and enzymes as promising candidates to functionalize biomaterial surfaces Biofouling 30 2014 483 499
4. C.D. Fjell, J.A. Hiss, R.E. Hancock, and G. Schneider Designing antimicrobial peptides: form follows function Nat. Rev. Drug Discov. 11 2012 37 51
5. R.M. Epand, and H.J. Vogel Diversity of antimicrobial peptides and their mechanisms of action Biochim. Biophys. Acta 1462 1999 11 28
6. B. Beutler LPS in microbial pathogenesis: promise and fulfilment J. Endotoxin Res. 8 2002 329 335
7. A. Wada, M. Kono, S. Kawauchi, Y. Takagi, T. Morikawa, and K. Funakoshi Rapid discrimination of Gram-positive and Gram-negative bacteria in liquid samples by using NaOH-sodium dodecyl sulfate solution and flow cytometry PLoS One 7 2012 e47093
8. R.M. Epand, and R.F. Epand Bacterial membrane lipids in the action of antimicrobial agents J. Pept. Sci. 17 2011 298 305
9. C. Ratledge, and S.G. Wilkinson Microbial Lipids 1988 Academic Press San Diego
10. D.E. Karageorgopoulos, R. Wang, X.H. Yu, and M.E. Falagas Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens J. Antimicrob. Chemother. 67 2012 255 268
11. E.W. Triplett Isolation of genes involved in nodulation competitiveness from Rhizobium leguminosarum bv. Trifolii T24 Proc. Natl. Acad. Sci. U. S. A. 85 1988 3810 3814
12. E.W. Triplett, and T.M. Barta Trifolitoxin production and nodulation are necessary for the expression of superior nodulation competitiveness by Rhizobium leguminosarum bv. Trifolii strain T24 on clover Plant Physiol. 85 1987 335 342
13. E.W. Triplett, B.T. Breil, and G.A. Splitter Expression of tfx and sensitivity to the rhizobial peptide antibiotic trifolitoxin in a taxonomically distinct group of alpha-proteobacteria including the animal pathogen Brucella abortus Appl. Environ. Microbiol. 60 1994 4163 4166
14. S.T. Hsu, E. Breukink, E. Tischenko, M.A. Lutters, K.B. de, R. Kaptein, A.M. Bonvin, and N.A. van Nuland The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics Nat. Struct. Mol. Biol. 11 2004 963 967
15. I. Wiedemann, E. Breukink, K.C. van, O.P. Kuipers, G. Bierbaum, K.B. de, and H.G. Sahl Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity J. Biol. Chem. 276 2001 1772 1779
16. R.E. Bishop The lipid A palmitoyltransferase PagP: molecular mechanisms and role in acterial pathogenesis Mol. Microbiol. 57 2005 900 912
17. K.L. Blake, C.P. Randall, and A.J. O'Neill In vitro studies indicate a high resistance potential for the lantibiotic nisin in Staphylococcus aureus and define a genetic basis for nisin resistance Antimicrob. Agents Chemother. 55 2011 2362 2368
18. K. Siegers, and K.D. Entian Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3 Appl. Environ. Microbiol. 61 1995 1082 1089
19. N.H. Lam, Z. Ma, and B.Y. Ha Electrostatic modification of the lipopolysaccharide layer: competing effects of divalent cations and polycationic or polyanionic molecules Soft Matter 10 2014 7528 7544
20. R.F. Epand, B.P. Mowery, S.E. Lee, S.S. Stahl, R.I. Lehrer, S.H. Gellman, and R.M. Epand Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides J. Mol. Biol. 379 2008 38 50
21. R.F. Epand, H. Sarig, A. Mor, and R.M. Epand Cell-wall interactions and the selective bacteriostatic activity of a miniature oligo-acyl-lysyl Biophys. J. 97 2009 2250 2257
22. J.V. Farizano, M.L. Pescaretti, F.E. Lopez, F.F. Hsu, and M.A. Delgado The PmrAB system-inducing conditions control both lipid A remodeling and O-antigen length distribution, influencing the Salmonella typhimurium-host interactions J. Biol. Chem. 287 2012 38778 38789
23. A.D. Gutu, N. Sgambati, P. Strasbourger, M.K. Brannon, M.A. Jacobs, E. Haugen, R.K. Kaul, H.K. Johansen, N. Hoiby, and S.M. Moskowitz Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems Antimicrob. Agents Chemother. 57 2013 2204 2215
24. T.L. Harris, R.J. Worthington, L.E. Hittle, D.V. Zurawski, R.K. Ernst, and C. Melander Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance ACS Chem. Biol. 9 2014 122 127
25. A.K. Miller, M.K. Brannon, L. Stevens, H.K. Johansen, S.E. Selgrade, S.I. Miller, N. Hoiby, and S.M. Moskowitz PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients Antimicrob. Agents Chemother. 55 2011 5761 5769
26. D. Marquardt, N. Kucerka, J. Katsaras, and T.A. Harroun α-Tocopherol's location in membranes is not affected by their composition Langmuir 31 2015 4464 4472
27. M. Herrmann, E. Schneck, T. Gutsmann, K. Brandenburg, and M. Tanaka Bacterial lipopolysaccharides form physically cross-linked, two-dimensional gels in the presence of divalent cations Soft Matter 11 2015 6037 6044
28. N. Voievoda, T. Schulthess, B. Bechinger, and J. Seelig Thermodynamic and biophysical analysis of the membrane-association of a histidine-rich peptide with efficient antimicrobial and transfection activities J. Phys. Chem. B 119 2015 9678 9687
29. K. Hu, Y. Jiang, Y. Xie, H. Liu, R. Liu, Z. Zhao, R. Lai, and L. Yang Small-anion selective transmembrane "holes" induced by an antimicrobial peptide too short to span membranes J. Phys. Chem. B 119 2015 8553 8560
30. A. Mularski, J.J. Wilksch, H. Wang, M.A. Hossain, J.D. Wade, F. Separovic, R.A. Strugnell, and M.L. Gee Atomic force microscopy reveals the mechanobiology of lytic peptide action on bacteria Langmuir 31 2015 6164 6171
31. K.M. Scherer, J.H. Spille, H.G. Sahl, F. Grein, and U. Kubitscheck The lantibiotic nisin induces lipid II aggregation, causing membrane instability and vesicle budding Biophys. J. 108 2015 1114 1124
32. E. Strandberg, and A.S. Ulrich AMPs and OMPs: is the folding and bilayer insertion of beta-stranded outer membrane proteins governed by the same biophysical principles as for alpha-helical antimicrobial peptides? Biochim. Biophys. Acta 1848 2015 1944 1954
33. R.M. Epand, and R.F. Epand Domains in bacterial membranes and the action of antimicrobial agents Mol. BioSyst. 5 2009 580 587
34. R.F. Epand, G. Wang, B. Berno, and R.M. Epand Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37 Antimicrob. Agents Chemother. 53 2009 3705 3714
35. R.M. Epand, S. Rotem, A. Mor, B. Berno, and R.F. Epand Bacterial membranes as predictors of antimicrobial potency J. Am. Chem. Soc. 130 2008 14346 14352
36. R.M. Epand, K. D'Souza, B. Berno, and M. Schlame Membrane curvature modulation of protein activity determined by NMR Biochim. Biophys. Acta 1848 2015 220 228
37. J.C. Bozelli Jr., E.T. Sasahara, M.R. Pinto, C.R. Nakaie, and S. Schreier Effect of head group and curvature on binding of the antimicrobial peptide tritrpticin to lipid membranes Chem. Phys. Lipids 165 2012 365 373
38. D. Koller, and K. Lohner The role of spontaneous lipid curvature in the interaction of interfacially active peptides with membranes Biochim. Biophys. Acta 1838 2014 2250 2259
39. B.S. Perrin Jr., A.J. Sodt, M.L. Cotten, and R.W. Pastor The curvature induction of surface-bound antimicrobial peptides piscidin 1 and piscidin 3 varies with lipid chain length J. Membr. Biol. 248 2015 455 467
40. K. Matsuzaki, K. Sugishita, N. Ishibe, M. Ueha, S. Nakata, K. Miyajima, and R.M. Epand Relationship of membrane curvature to the formation of pores by magainin 2 Biochemistry 37 1998 11856 11863
41. S. Bobone, D. Roversi, L. Giordano, Z.M. De, F. Formaggio, C. Toniolo, Y. Park, and L. Stella The lipid dependence of antimicrobial peptide activity is an unreliable experimental test for different pore models Biochemistry 51 2012 10124 10126
42. B. Bechinger The SMART model: soft membranes adapt and respond, also transiently, in the presence of antimicrobial peptides J. Pept. Sci. 21 2015 346 355
43. J. Pogliano, N. Pogliano, and J.A. Silverman Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins J. Bacteriol. 194 2012 4494 4504
44. T.T. Tran, D. Panesso, N.N. Mishra, E. Mileykovskaya, Z. Guan, J.M. Munita, J. Reyes, L. Diaz, G.M. Weinstock, B.E. Murray, Y. Shamoo, W. Dowhan, A.S. Bayer, and C.A. Arias Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids MBio. 4 2013 e00281-e00213
45. S. Jordan, M.I. Hutchings, and T. Mascher Cell envelope stress response in Gram-positive bacteria FEMS Microbiol. Rev. 32 2008 107 146
46. M. MISIEK, O.B. FARDIG, A. GOUREVITCH, D.L. JOHNSON, I.R. HOOPER, and J. LEIN Telomycin, a new antibiotic Antibiot. Annu. 5 2001 852 855
47. J.C. Sheehan, D. Mania, S. Nakamura, J.A. Stock, and K. Maeda The structure of telomycin J. Am. Chem. Soc. 90 1968 462 470
48. C. Fu, L. Keller, A. Bauer, M. Brönstrup, A. Froidbise, P. Hammann, J. Herrmann, G. Mondesert, M. Kurz, M. Schiell, D. Schummer, L. Toti, J. Wink, and R. Muller Biosynthetic Studies of Telomycin Reveal New Lipopeptides with Enhanced Activity J. Am. Chem. Soc. 137 2015 7692 7705
49. B. Oliva, W.M. Maiese, M. Greenstein, D.B. Borders, and I. Chopra Mode of action of the cyclic depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic J. Antimicrob. Chemother. 32 1993 817 830
50. K. Scheinpflug, O. Krylova, H. Nikolenko, C. Thurm, and M. Dathe Evidence for a novel mechanism of antimicrobial action of a cyclic R-,W-rich hexapeptide PLoS ONE 10 2015 e0125056
51. D.A. Phoenix, F. Harris, M. Mura, and S.R. Dennison The increasing role of phosphatidylethanolamine as a lipid receptor in the action of host defence peptides Prog. Lipid Res. 59 2015 26 37
52. A. Fredenhagen, F. Marki, G. Fendrich, and W. Marki j. Gruner, J. van Oostrum, F. Raschdorf, and H.H. Peter, Duramycin B and C, two new lanthionine-containing antibiotics as inhibitors of phospholipase A2, and structural revision of duramycin and cinnamycin G. Jung, H.G. Sahl, Nisin and Lantibiotics 1991 ESCOM Leiden 131 140
53. H.G. Sahl, R.W. Jack, and G. Bierbaum Biosynthesis and biological activities of lantibiotics with unique post-translational modifications Eur. J. Biochem. 230 1995 827 853
54. E.A. Dunkley Jr., S. Clejan, A.A. Guffanti, and T.A. Krulwich Large decreases in membrane phosphatidylethanolamine and diphosphatidylglycerol upon mutation to duramycin resistance do not change the protonophore resistance of Bacillus subtilis Biochim. Biophys. Acta 943 1988 13 18
55. K. Iwamoto, T. Hayakawa, M. Murate, A. Makino, K. Ito, T. Fujisawa, and T. Kobayashi Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin Biophys. J. 93 2007 1608 1619
56. F. Marki, E. Hanni, A. Fredenhagen, and J. van Oostrum Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2 Biochem. Pharmacol. 42 1991 2027 2035
57. G. Machaidze, A. Ziegler, and J. Seelig Specific binding of Ro 09-0198 (cinnamycin) to phosphatidylethanolamine: a thermodynamic analysis Biochemistry 41 2002 1965 1971
58. G. Machaidze, and J. Seelig Specific binding of cinnamycin (Ro 09-0198) to phosphatidylethanolamine. Comparison between micellar and membrane environments Biochemistry 42 2003 12570 12576
59. K. Hosoda, M. Ohya, T. Kohno, T. Maeda, S. Endo, and K. Wakamatsu Structure determination of an immunopotentiator peptide, cinnamycin, complexed with lysophosphatidylethanolamine by 1H-NMR1 J. Biochem. 119 1996 226 230
60. C.K. Wang, H.P. Wacklin, and D.J. Craik Cyclotides insert into lipid bilayers to form membrane pores and destabilize the membrane through hydrophobic and phosphoethanolamine-specific interactions J. Biol Chem. 287 2012 43884 43898
61. R. Burman, A.A. Stromstedt, M. Malmsten, and U. Goransson Cyclotide-membrane interactions: defining factors of membrane binding, depletion and disruption Biochim. Biophys. Acta 1808 2011 2665 2673
62. S.T. Henriques, Y.H. Huang, M.A. Castanho, L.A. Bagatolli, S. Sonza, G. Tachedjian, N.L. Daly, and D.J. Craik Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions J. Biol Chem. 287 2012 33629 33643
63. S.T. Henriques, and D.J. Craik Importance of the cell membrane on the mechanism of action of cyclotides ACS Chem. Biol. 7 2012 626 636
64. M.D. Collins, and D. Jones Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication Microbiol. Rev. 45 1981 316 354
65. E. Lemma, G. Unden, and A. Kroger Menaquinone is an obligatory component of the chain catalyzing succinate respiration in Bacillus subtilis Arch. Microbiol. 155 1990 62 67
66. S.K. Farrand, and H.W. Taber Changes in menaquinone concentration during growth and early sporulation in Bacillus subtilis J. Bacteriol. 117 1974 324 326
67. A. Das, J. Hugenholtz, H. Van Halbeek, and L.G. Ljungdahl Structure and function of a menaquinone involved in electron transport in membranes of Clostridium thermoautotrophicum and Clostridium thermoaceticum J. Bacteriol. 171 1989 5823 5829
68. H. Hamamoto, M. Urai, K. Ishii, J. Yasukawa, A. Paudel, M. Murai, T. Kaji, T. Kuranaga, K. Hamase, T. Katsu, J. Su, T. Adachi, R. Uchida, H. Tomoda, M. Yamada, M. Souma, H. Kurihara, M. Inoue, and K. Sekimizu Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane Nat. Chem. Biol. 11 2015 127 133
69. O.H. Morand, J.D. Aebi, H. Dehmlow, Y.H. Ji, N. Gains, H. Lengsfeld, and J. Himber Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin J. Lipid Res. 38 1997 373 390
70. R.K. Dhiman, S. Mahapatra, R.A. Slayden, M.E. Boyne, A. Lenaerts, J.C. Hinshaw, S.K. Angala, D. Chatterjee, K. Biswas, P. Narayanasamy, M. Kurosu, and D.C. Crick Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence Mol. Microbiol. 72 2009 85 97
71. J.G. Hurdle, A.J. O'Neill, I. Chopra, and R.E. Lee Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections Nat. Rev. Microbiol. 9 2011 62 75
72. W. Zhao, T. Rog, a.A. Gurtovenko, I. Vattulainen, and M. Karttunen Role of phosphatidylglycerols in the stability of bacterial membranes Biochimie 90 2008 930 938
73. W. Dowhan Molecular basis for membrane phospholipid diversity: why are there so many lipids? Annu. Rev. Biochem. 66 1997 199 232
74. M. Debono, M. Barnhart, C.B. Carrell, J.A. Hoffmann, J.L. Occolowitz, B.J. Abbott, D.S. Fukuda, R.L. Hamill, K. Biemann, and W.C. Herlihy A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation J. Antibiot. 40 1987 761 777
75. D. Jung, A. Rozek, M. Okon, and R.E.W. Hancock Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin Chem. Biol. 11 2004 949 957
76. A.B. Hachmann, E. Sevim, A. Gaballa, D.L. Popham, H. Antelmann, and J.D. Helmann Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in Bacillus subtilis Antimicrob. Agents Chemother. 55 2011 4326 4337
77. C.M. Ernst, and A. Peschel Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids Mol. Microbiol. 80 2011 290 299
78. A. Peschel, R.W. Jack, M. Otto, L.V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher, W.F. Nieuwenhuizen, G. Jung, A. Tarkowski, K.P. van Kessel, and J.A. van Strijp Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine J. Exp. Med. 193 2001 1067 1076
79. C.M. Ernst, S. Kuhn, C.J. Slavetinsky, B. Krismer, S. Heilbronner, C. Gekeler, D. Kraus, S. Wagner, and A. Peschel The Lipid-modifying Multiple Peptide Resistance Factor Is an Oligomer Consisting of Distinct Interacting Synthase and Flippase Subunits, MBio 6 2015
80. J.S. Gunn Bacterial modification of LPS and resistance to antimicrobial peptides J. Endotoxin Res. 7 2001 57 62
81. R.F. Epand, J.E. Pollard, J.O. Wright, P.B. Savage, and R.M. Epand Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins Antimicrob. Agents Chemother. 54 2010 3708 3713
82. K. Goldberg, H. Sarig, F. Zaknoon, R.F. Epand, R.M. Epand, and A. Mor Sensitization of Gram-negative bacteria by targeting the membrane potential FASEB J. 27 2013 3818 3826
83. F. Zaknoon, K. Goldberg, H. Sarig, R.F. Epand, R.M. Epand, and A. Mor Antibacterial properties of an oligo-acyl-lysyl hexamer targeting Gram-negative species Antimicrob. Agents Chemother. 56 2012 4827 4832
84. L. Ejim, M.A. Farha, S.B. Falconer, J. Wildenhain, B.K. Coombes, M. Tyers, E.D. Brown, and G.D. Wright Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy Nat. Chem. Biol. 7 2011 348 350
85. G. Kaneti, H. Sarig, I. Marjieh, Z. Fadia, and A. Mor Simultaneous breakdown of multiple antibiotic resistance mechanisms in S. aureus FASEB J. 27 2013 4834 4843